AvePoint Jumps 15% as Retail Attention Spikes Before Q3 Results

AVPT has had a strong week, gaining 15.2% to close at $16.51, putting it within striking distance of the mean analyst price target heading into Q3 earnings on November 5.

The most striking signal this week comes not from short sellers but from retail attention. The ORTEX Alt Data layer's Wikipedia and ORTEX page-view composite hit a z-score of 6.3 against AVPT's own 90-day history, a level that suggests an unusually sharp spike in retail interest around the stock. That kind of attention surge, arriving less than two weeks before an earnings print, sets the context for everything else in the positioning data.

The borrow market tells a relaxed story. Availability sits at roughly 7,792%, meaning shares to borrow are plentiful relative to actual short demand, effectively no squeeze pressure exists in the lending pool. Short interest amounts to 5.5% of the free float, up about 14% over the past month in share terms, but the absolute level has barely moved this week and cost to borrow remains negligible at 0.55%. The borrow market, in short, is not where the action is. Options traders are aligned with the bullish price move: the put/call ratio dropped to 0.05 this week, nearly 1.5 standard deviations below its 20-day average of 0.06, a reading near the lowest of the past year. That reflects heavy call-side activity relative to put buying, consistent with the stock's sharp rally but also with elevated expectations heading into the print.

The Street is broadly constructive, with the consensus at hold and the mean price target at $16.81, just above the current price. BMO Capital initiated with an Outperform and a $17 target in early October, the most recent analyst action of note. Before that, Stephens raised its target from $16 to $17 while keeping Overweight. The bull case rests on mid-20% ARR growth, less than 10% penetration of the Microsoft 365 addressable market, and a path to $1 billion ARR by fiscal 2029. Bears point to the single-platform concentration risk: more than 90% of revenue is tied to protecting Microsoft products, leaving AVPT exposed if Microsoft extends its native toolset. The EV/EBITDA multiple of 26x and a price/book of 5.2x have both expanded over the past month alongside the stock's rally, so the valuation is less forgiving than it was. The factor score for analyst recommendation differential ranks in the 92nd percentile, the highest-conviction signal in the factor deck, while EPS surprise sits in the 82nd percentile, reflecting a track record of beating estimates. The forward earnings yield factor ranks in only the 10th percentile, a reminder that the growth premium is already priced in.

One register item warrants disclosure. Zhijian Lu filed a Schedule 13D/A on AVPT in October 2025, signalling activist intent at a 5.5% stake. That filing is now a year old and positions are as-last-disclosed, a holder who has moved below 5% has no obligation to update. Lu also appears in the institutional table holding roughly 4.9% of shares as of October 2025. Separately, Temasek-affiliated Anchor IV holds 9.4% and BlackRock added over 1.8 million shares in the most recent quarter, bringing its stake to 6.8% of shares. Insider activity over the past 90 days has been net negative, with the Chief Legal Officer selling just over $1.1 million in a 10b5-1 plan sale on October 20 and several smaller plan-driven sales in September. Because these were all pre-arranged plan transactions, they carry limited signal about near-term conviction. The CFO's activity has been limited to routine tax-withholding share surrenders.

AVPT reported Q3 last August and fell 4.6% on the day before recovering to a 2.6% gain over the following five trading sessions. Peers have had a broadly strong week: VERX gained 15.1%, FROG surged 19.3%, and RPD added 18.2%, so AVPT's 15% move is broadly in line with a software cohort running hot rather than an idiosyncratic re-rating.

With Q3 results due November 5 and the stock trading near the top of its analyst target range, the question heading into the print is whether ARR growth and NRR trends can justify the expanded multiples the rally has baked in.